Appen Limited
Appen Limited (APPEF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Appen Limited (APPEF), featuring income statements, balance sheets, and cash flow data.
Appen Limited (APPEF) Income Statement & Financial Overview
Analyze Appen Limited’s APPEF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $182.84M | $172.34M | $139.89M | $67.21M |
| Cost of Revenue | $172.31M | $171.55M | $147.49M | $59.28M |
| Gross Profit | $10.53M | $794649.00 | -$7.59M | $7.93M |
| Gross Profit Ratio | $0.06 | $0.005 | -$0.05 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $236000.00 | $236000.00 |
| SG&A Expenses | $21.59M | $22.61M | $17.33M | $7.46M |
| Operating Expenses | $20.27M | $22.61M | $16.96M | $48.57M |
| Total Costs & Expenses | -$192.58M | $194.15M | $164.45M | $107.85M |
| Interest Income | $462921.00 | $267415.00 | $250413.00 | $325898.00 |
| Interest Expense | $624793.00 | $613839.00 | $648987.00 | $0.00 |
| Depreciation & Amortization | $18.19M | $17.16M | $19.18M | $14.69M |
| EBITDA | $15.41M | -$9.18M | $3.17M | $3.17M |
| EBITDA Ratio | $0.08 | -$0.05 | -$0.04 | $0.05 |
| Operating Income | -$9.75M | -$21.81M | -$24.56M | -$11.53M |
| Operating Income Ratio | -$0.05 | -$0.13 | -$0.18 | -$0.17 |
| Other Income/Expenses (Net) | $6.33M | -$5.14M | -$60.68M | -$41.09M |
| Income Before Tax | -$3.41M | -$26.95M | -$85.24M | -$40.85M |
| Income Before Tax Ratio | -$0.02 | -$0.16 | -$0.61 | -$0.61 |
| Income Tax Expense | $1513.00 | $22791.00 | -$7.23M | $3.46M |
| Net Income | -$3.41M | -$26.97M | -$78.01M | -$37.38M |
| Net Income Ratio | -$0.02 | -$0.16 | -$0.56 | -$0.56 |
| EPS | -$0.01 | -$0.12 | -$0.52 | -$0.24 |
| Diluted EPS | -$0.01 | -$0.12 | -$0.52 | -$0.24 |
| Weighted Avg Shares Outstanding | $260.74M | $220.14M | $148.75M | $155.40M |
| Weighted Avg Shares Outstanding (Diluted) | $260.74M | $220.14M | $148.75M | $155.41M |
The company's financials show resilient growth, with revenue advancing from $67.21M in Q3 2023 to $182.84M in Q4 2024. Gross profit remained healthy with margins at 6% in Q4 2024 compared to 12% in Q3 2023. Operating income hit -$9.75M last quarter, sustaining a consistent -5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $15.41M. Net income rose to -$3.41M, while earnings per share reached -$0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan